Загрузка...
Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis
BACKGROUND: With increasing frequency of resistant Gram-negative bacteria, temocillin has potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes temocillin breakpoints and reclassifies isolates with an MIC of 0.001–16 mg/L as ‘susceptible, increased exposure’ necessitating 6...
Сохранить в:
| Опубликовано в: : | JAC Antimicrob Resist |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210019/ https://ncbi.nlm.nih.gov/pubmed/34223083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlab005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|